4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-000956
Options or other derivatives
- President, CMO acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Huang Jane President, CMO | 2025-02-04 | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X05/primarydocument.xml…